Arunabh Choudhury
New Delhi, DL 110025, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Machine Learning-Driven Ensemble Screening of Multitarget Kinase Inhibitors for Tauopathy-Associated Neurodegeneration Using All-Atom and Steered MD Simulations.
Journal: ACS chemical neuroscience
Published: April 17, 2026
Synergistic effect of the rifaximin-berberine combination against Klebsiella pneumoniae: RfaH targeting supported by MD simulation.
Journal: Biomolecules & biomedicine
Published: December 20, 2025
Integrated Virtual Screening and Molecular Dynamics Simulation Study to Discover Potential Activators of γ-Aminobutyric Acid B Receptor 1 for Therapeutic Targeting of Neurodegenerative Diseases.
Journal: Chemical biology & drug design
Published: December 18, 2025
Repurposing rifaximin against Klebsiella pneumoniae via targeting of transcription anti-termination protein RfaH for novel antimicrobial development.
Journal: Biochemical and biophysical research communications
Published: September 25, 2025
Targeting tau hyperphosphorylation-mediated neuroinflammation in Alzheimer's disease via ABL1 kinase inhibition: Insights from microsecond MD simulation and MM/PBSA analyses.
Journal: International journal of biological macromolecules
Published: May 30, 2025
Structure-guided discovery of tau-phosphorylating kinase DYRK1A inhibitors for therapeutic targeting of neuroinflammatory diseases: Insights from microsecond MD simulation and MMPBSA analyses.
Journal: Biochemical and biophysical research communications
Published: May 02, 2025
Repurposing resveratrol for redox-mediated inhibition of MTH1 in breast cancer.
Journal: Scientific reports
Published: April 29, 2025
Multi-targeted approach via apigenin-7-O-glucoside for therapeutic intervention of Tau phosphorylating kinases in Alzheimer's disease.
Journal: 3 Biotech
Published: April 27, 2025
Identification of potential inhibitors of Fyn-Kinase from bioactive phytochemicals of Berberis lycium for therapeutic targeting of neurodegenerative disease.
Journal: Journal of biomolecular structure & dynamics
Published: February 24, 2025
Therapeutic Targeting of Interleukin-2-Inducible T-Cell Kinase (ITK) for Cancer and Immunological Disorders: Potential Next-Generation ITK Inhibitors.
Journal: Omics : a journal of integrative biology
Published: February 19, 2025
Mechanistic insights into the inhibition of microtubule affinity-regulating kinase 4 by Syringic acid: A computational and experimental study.
Journal: International journal of biological macromolecules
Published: February 15, 2025
Identification of potential inhibitors of interleukin-2-inducible T-cell kinase: insights from docking, molecular dynamics, MMPBSA and free energy landscape studies.
Journal: Amino acids
Published: January 24, 2025
Last Updated: 09/26/2026